QQQ   307.69 (+2.25%)
AAPL   149.01 (+2.46%)
MSFT   258.88 (+2.43%)
META   181.25 (+18.37%)
GOOGL   106.38 (+5.92%)
AMZN   110.31 (+4.91%)
TSLA   187.73 (+3.48%)
NVDA   211.83 (+1.15%)
NIO   11.99 (-0.91%)
BABA   110.92 (-1.68%)
AMD   85.52 (+1.04%)
T   20.14 (-0.20%)
MU   63.29 (+1.10%)
F   14.07 (+2.03%)
CGC   3.15 (+2.27%)
GE   82.48 (+0.19%)
DIS   109.77 (+0.35%)
AMC   6.10 (+6.83%)
PFE   43.70 (-0.61%)
PYPL   86.28 (+4.06%)
NFLX   360.80 (-0.33%)
QQQ   307.69 (+2.25%)
AAPL   149.01 (+2.46%)
MSFT   258.88 (+2.43%)
META   181.25 (+18.37%)
GOOGL   106.38 (+5.92%)
AMZN   110.31 (+4.91%)
TSLA   187.73 (+3.48%)
NVDA   211.83 (+1.15%)
NIO   11.99 (-0.91%)
BABA   110.92 (-1.68%)
AMD   85.52 (+1.04%)
T   20.14 (-0.20%)
MU   63.29 (+1.10%)
F   14.07 (+2.03%)
CGC   3.15 (+2.27%)
GE   82.48 (+0.19%)
DIS   109.77 (+0.35%)
AMC   6.10 (+6.83%)
PFE   43.70 (-0.61%)
PYPL   86.28 (+4.06%)
NFLX   360.80 (-0.33%)
QQQ   307.69 (+2.25%)
AAPL   149.01 (+2.46%)
MSFT   258.88 (+2.43%)
META   181.25 (+18.37%)
GOOGL   106.38 (+5.92%)
AMZN   110.31 (+4.91%)
TSLA   187.73 (+3.48%)
NVDA   211.83 (+1.15%)
NIO   11.99 (-0.91%)
BABA   110.92 (-1.68%)
AMD   85.52 (+1.04%)
T   20.14 (-0.20%)
MU   63.29 (+1.10%)
F   14.07 (+2.03%)
CGC   3.15 (+2.27%)
GE   82.48 (+0.19%)
DIS   109.77 (+0.35%)
AMC   6.10 (+6.83%)
PFE   43.70 (-0.61%)
PYPL   86.28 (+4.06%)
NFLX   360.80 (-0.33%)
QQQ   307.69 (+2.25%)
AAPL   149.01 (+2.46%)
MSFT   258.88 (+2.43%)
META   181.25 (+18.37%)
GOOGL   106.38 (+5.92%)
AMZN   110.31 (+4.91%)
TSLA   187.73 (+3.48%)
NVDA   211.83 (+1.15%)
NIO   11.99 (-0.91%)
BABA   110.92 (-1.68%)
AMD   85.52 (+1.04%)
T   20.14 (-0.20%)
MU   63.29 (+1.10%)
F   14.07 (+2.03%)
CGC   3.15 (+2.27%)
GE   82.48 (+0.19%)
DIS   109.77 (+0.35%)
AMC   6.10 (+6.83%)
PFE   43.70 (-0.61%)
PYPL   86.28 (+4.06%)
NFLX   360.80 (-0.33%)
NYSE:BAX

Baxter International - BAX Stock Forecast, Price & News

$46.47
+0.19 (+0.41%)
(As of 02/2/2023 09:46 AM ET)
Add
Compare
Today's Range
$46.10
$46.67
50-Day Range
$43.64
$56.53
52-Week Range
$43.25
$89.70
Volume
412,897 shs
Average Volume
6.19 million shs
Market Capitalization
$23.43 billion
P/E Ratio
N/A
Dividend Yield
2.54%
Price Target
$62.93

Baxter International MarketRank™ Forecast

Analyst Rating
Hold
2.15 Rating Score
Upside/​Downside
36.0% Upside
$62.93 Price Target
Short Interest
Healthy
1.40% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-1.95
Upright™ Environmental Score
News Sentiment
0.14mentions of Baxter International in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$2.66 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.81 out of 5 stars

Medical Sector

39th out of 1,030 stocks

Surgical & Medical Instruments Industry

4th out of 105 stocks


BAX stock logo

About Baxter International (NYSE:BAX) Stock

Baxter International, Inc. engages in the provision of a portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies, premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software, and services. It operates through the following segment: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Stock News Headlines

This Stock Has Room To Run
Analysts believe this stock's product demand could rise quickly in the next few years.
This Stock Has Room To Run
Analysts believe this stock's product demand could rise quickly in the next few years.
3 Dividend Stocks Trading Near Their 52-Week Lows
BAX Baxter International Inc.
This Health Care Stock Has Just What the Doctor Ordered
See More Headlines
Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Company Calendar

Last Earnings
10/27/2021
Ex-Dividend for 1/3 Dividend
12/01/2022
Dividend Payable
1/03/2023
Today
2/02/2023
Next Earnings (Confirmed)
2/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
07181310
Employees
60,000
Year Founded
1931

Price Target and Rating

Average Stock Price Forecast
$62.93
High Stock Price Forecast
$91.00
Low Stock Price Forecast
$51.00
Forecasted Upside/Downside
+35.4%
Consensus Rating
Hold
Rating Score (0-4)
2.15
Research Coverage
13 Analysts

Profitability

Net Income
$1.28 billion
Pretax Margin
-15.56%

Debt

Sales & Book Value

Annual Sales
$12.78 billion
Cash Flow
$5.54 per share
Book Value
$18.22 per share

Miscellaneous

Free Float
503,062,000
Market Cap
$23.43 billion
Optionable
Optionable
Beta
0.54

Social Links


Key Executives

  • Joe Almeida
    Chairman, President & Chief Executive Officer
  • James K. Saccaro
    Chief Financial Officer & Executive Vice President
  • Paulo Henrique Bolgar
    Vice President-Research & Development
  • Tobi Karchmer
    Chief Medical Officer & Senior Vice President
  • Talvis Love
    Chief Information Officer & Senior Vice President













BAX Stock - Frequently Asked Questions

Should I buy or sell Baxter International stock right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 1 sell rating, 9 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares.
View BAX analyst ratings
or view top-rated stocks.

What is Baxter International's stock price forecast for 2023?

13 equities research analysts have issued 12-month price objectives for Baxter International's shares. Their BAX share price forecasts range from $51.00 to $91.00. On average, they anticipate the company's stock price to reach $62.93 in the next twelve months. This suggests a possible upside of 36.0% from the stock's current price.
View analysts price targets for BAX
or view top-rated stocks among Wall Street analysts.

How have BAX shares performed in 2023?

Baxter International's stock was trading at $50.97 at the beginning of 2023. Since then, BAX stock has decreased by 9.2% and is now trading at $46.28.
View the best growth stocks for 2023 here
.

Are investors shorting Baxter International?

Baxter International saw a increase in short interest in December. As of December 30th, there was short interest totaling 7,410,000 shares, an increase of 30.7% from the December 15th total of 5,670,000 shares. Based on an average daily volume of 4,850,000 shares, the short-interest ratio is currently 1.5 days.
View Baxter International's Short Interest
.

When is Baxter International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023.
View our BAX earnings forecast
.

How can I listen to Baxter International's earnings call?

Baxter International will be holding an earnings conference call on Thursday, February 9th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) announced its quarterly earnings results on Wednesday, October, 27th. The medical instruments supplier reported $1.02 EPS for the quarter, topping analysts' consensus estimates of $0.94 by $0.08. The medical instruments supplier had revenue of $3.23 billion for the quarter, compared to analysts' expectations of $3.23 billion. Baxter International had a negative net margin of 16.12% and a positive trailing twelve-month return on equity of 22.65%. Baxter International's revenue for the quarter was up 8.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.83 earnings per share.
Read the conference call transcript
.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Tuesday, November 15th. Stockholders of record on Friday, December 2nd will be given a dividend of $0.29 per share on Tuesday, January 3rd. This represents a $1.16 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend is Thursday, December 1st.
Read our dividend analysis for BAX
.

Is Baxter International a good dividend stock?

Baxter International (NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 2.57%.
Read our dividend analysis for BAX.

What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by many different institutional and retail investors. Top institutional shareholders include Coho Partners Ltd. (0.39%), New York State Common Retirement Fund (0.30%), Sumitomo Mitsui Trust Holdings Inc. (0.28%), River Road Asset Management LLC (0.14%), New York State Teachers Retirement System (0.10%) and Bartlett & Co. LLC (0.06%). Insiders that own company stock include Albert P L Stroucken, Andrew Frye, Brian Stevens, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth and Sean Martin.
View institutional ownership trends
.

How do I buy shares of Baxter International?

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $46.28.

How much money does Baxter International make?

Baxter International (NYSE:BAX) has a market capitalization of $23.33 billion and generates $12.78 billion in revenue each year. The medical instruments supplier earns $1.28 billion in net income (profit) each year or ($4.72) on an earnings per share basis.

How many employees does Baxter International have?

The company employs 60,000 workers across the globe.

Does Baxter International have any subsidiaries?
The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..
Read More
How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The official website for the company is www.baxter.com. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at global_corp_investor_relations@baxter.com, or via fax at 224-948-1813.

This page (NYSE:BAX) was last updated on 2/2/2023 by MarketBeat.com Staff